MedPlus Health Services Limited
NSE: MEDPLUS · Pharmacy Retail
Snapshot
Unlock MedPlus Health Services Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
MedPlus Health Services Limited is a prominent Indian pharmacy retailer offering pharmaceutical products, wellness items, and fast-moving consumer goods. The company operates through an extensive network of physical retail stores, an online platform, and provides wholesale and diagnostic laboratory services.
Business Model
The company generates revenue through the retail sale of medicines and consumer goods, wholesale distribution, and the provision of pathological laboratory testing services. It leverages a hybrid model combining physical store footprints with digital e-commerce capabilities.
- Store Count (as of March 2021):1,659
Growth Outlook
Growth is driven by the expansion of the retail store network and the scaling of its online pharmacy platform. The company continues to diversify its service offerings through private label manufacturing and diagnostic testing.
Key Risks
- Regulatory Compliance. The pharmaceutical retail sector is subject to stringent government regulations regarding drug pricing and licensing.
- Intense Competition. The company faces significant competition from both traditional local pharmacies and rapidly growing e-pharmacy aggregators.
- Supply Chain Dependencies. Operational efficiency relies on maintaining a robust supply chain for pharmaceutical procurement and inventory management.
- Geographic Concentration. A significant portion of the store network is concentrated in specific southern Indian states, creating regional dependency.
Start your research today
Unlock AI insights, financials, peers and live data on MedPlus Health Services Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹7,587 Cr
TTM · consolidated
NET PROFIT
₹211 Cr
TTM · consolidated
EPS
₹17.64
TTM · consolidated
RETURN ON EQUITY
10.8%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
12.6%
TTM · consolidated
P/E
33.8×
Q2 FY27 · consolidated
EV/EBITDA
9.9x
Q2 FY27 · consolidated
EBITDA MARGIN
9.4%
TTM · consolidated
NET PROFIT MARGIN
2.8%
Q2 FY27 · consolidated
DEBT TO EQUITY
0.0x
Q2 FY27 · consolidated
Peers · Pharmacy Retail
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
MedPlus Health Services LimitedMEDPLUS | ₹7,166 Cr | 33.8× | 9.88 | 20.6% | 9.4% | 10.8% | 12.6% | -21.8% |
Entero Healthcare Solutions LimitedENTERO | ₹6,839 Cr | 54.5× | 22.05 | 31.9% | 4.6% | 9.8% | 14.2% | +42.2% |
Health X Platform LimitedSASTASUNDR | ₹913 Cr | -44.5× | — | 28.8% | -1.4% | -4.0% | -21.6% | -2.9% |
As of Q2 FY27
Financials
MedPlus Health Services Limited
NSE: MEDPLUS · Pharmacy Retail
Snapshot
Unlock MedPlus Health Services Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
MedPlus Health Services Limited is a prominent Indian pharmacy retailer offering pharmaceutical products, wellness items, and fast-moving consumer goods. The company operates through an extensive network of physical retail stores, an online platform, and provides wholesale and diagnostic laboratory services.
Business Model
The company generates revenue through the retail sale of medicines and consumer goods, wholesale distribution, and the provision of pathological laboratory testing services. It leverages a hybrid model combining physical store footprints with digital e-commerce capabilities.
- Store Count (as of March 2021):1,659
Growth Outlook
Growth is driven by the expansion of the retail store network and the scaling of its online pharmacy platform. The company continues to diversify its service offerings through private label manufacturing and diagnostic testing.
Key Risks
- Regulatory Compliance. The pharmaceutical retail sector is subject to stringent government regulations regarding drug pricing and licensing.
- Intense Competition. The company faces significant competition from both traditional local pharmacies and rapidly growing e-pharmacy aggregators.
- Supply Chain Dependencies. Operational efficiency relies on maintaining a robust supply chain for pharmaceutical procurement and inventory management.
- Geographic Concentration. A significant portion of the store network is concentrated in specific southern Indian states, creating regional dependency.
Start your research today
Unlock AI insights, financials, peers and live data on MedPlus Health Services Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹7,587 Cr
TTM · consolidated
NET PROFIT
₹211 Cr
TTM · consolidated
EPS
₹17.64
TTM · consolidated
RETURN ON EQUITY
10.8%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
12.6%
TTM · consolidated
P/E
33.8x
Q2 FY27 · consolidated
EV/EBITDA
9.9x
Q2 FY27 · consolidated
EBITDA MARGIN
9.4%
TTM · consolidated
NET PROFIT MARGIN
2.8%
Q2 FY27 · consolidated
DEBT TO EQUITY
0.0x
Q2 FY27 · consolidated
Peers · Pharmacy Retail
As of Q2 FY27